HIGH
Ketamine Hydrochloride, 50mg/5 mL (10mg/mL), Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0156-02.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect
HIGH
Dr. Reddy's Laboratories Recalled Succinylcholine Injection Over Safety Concerns
Dr. Reddy's Laboratories recalled 571 vials of Succinylcholine Chloride Injection on September 26, 2025. The recall stems from out-of-specification results during stability testing, indicating a decreased preservative concentration. The product is used for intravenous or intramuscular administration and is available by prescription only.
Quick Facts at a Glance
- Recall Date
- September 26, 2025
- Hazard Level
- HIGH
- Brands
- SUCCINYLCHOLINE, Dr. Reddy's Laboratories
- Category
- Health & Personal Care
- Sold At
- Multiple Retailers
- Geographic Scope
- 1 states
- At-Risk Groups
- GENERAL
Hazard Information
Out-of-Specification (OOS) result during the 6-month stability testing; decreased preservative concentration.
What You Should Do
Consumers and healthcare providers should stop using this product immediately. Contact Dr. Reddy's Laboratories, Inc. or your healthcare provider for guidance. Notification method: Letter
Product Details
The recalled product is Succinylcholine Chloride Injection, USP, 200 mg/10 mL, distributed in 25 x 10 mL multiple-dose vials. The NDC number is 43598-666-25. This product was distributed nationwide.
The Hazard
The recall is due to out-of-specification results during six-month stability testing. The decreased preservative concentration raises concerns about the product's safety and efficacy.
Reported Incidents
No specific incidents or injuries have been reported related to this recall. The high hazard classification indicates potential serious risks.
What to Do
Stop using the product immediately. Contact Dr. Reddy's Laboratories or your healthcare provider for further guidance.
Contact Information
For more information, call Dr. Reddy's Laboratories at their customer service line or visit their official website.
Key Facts
- 571 vials recalled
- Out-of-specification results during stability testing
- Used for intravenous or intramuscular administration
- Available by prescription only
Get Alerts for Health & Personal Care Recalls
Get notified about recalls in categories you care about.
Safety Assessment
Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER
Product Classification
Product TypeSuccinylcholine Chloride Injection
Sold At
Multiple Retailers
Product Details
Model Numbers
Lot # K250048
UPC Codes
43598-666
43598-666-11
43598-666-25
Affected States
ALL
Report Date
October 15, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE
Related Recalls
HIGH
Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-695-01 - Carton NDC [60687-695-11- Unit Dose]
CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024. As a result, it cannot monitor the quality program and hence cannot assure that products meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess, rendering the products adulterated.
SUCRALFATE
CGMP Deviations:
HIGH
Hydromorphone HCL PF, 10mg/50 mL (0.2mg/mL) in NACL, Injection for IV use, 50 mL Syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0104-05.
Labeling: Incorrect or Missing Lot and/or Exp Date
STAQ Pharma
Labeling: Incorrect